The histone deacetylase 9 gene encodes multiple protein isoforms
about
Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseasesHistone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent mannerNew role for hPar-1 kinases EMK and C-TAK1 in regulating localization and activity of class IIa histone deacetylasesAssociation with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.Role for SUMO modification in facilitating transcriptional repression by BKLF.Multiple domains of the Receptor-Interacting Protein 140 contribute to transcription inhibitionRegulation of class IIa HDAC activities: it is not only matter of subcellular localizationCRM1 mediates nuclear export of HDAC7 independently of HDAC7 phosphorylation and association with 14-3-3sDifferential effects of binge methamphetamine injections on the mRNA expression of histone deacetylases (HDACs) in the rat striatumSystems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney diseaseThe Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and menHepatic gene expression profiling reveals protective responses in Atlantic salmon vaccinated against furunculosisClass II histone deacetylases: from sequence to function, regulation, and clinical implication.Predicting targeted drug combinations based on Pareto optimal patterns of coexpression network connectivityA new isoform of the histone demethylase JMJD2A/KDM4A is required for skeletal muscle differentiation.Histone deacetylase 9 (HDAC9) regulates the functions of the ATDC (TRIM29) protein.Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis developmentHDAC1, HDAC4, and HDAC9 Bind to PC3/Tis21/Btg2 and Are Required for Its Inhibition of Cell Cycle Progression and Cyclin D1 Expression.Neuroprotection by histone deacetylase-related protein.Histone deacetylases 9 and 10 are required for homologous recombination.Histone deacetylase 9 is a negative regulator of adipogenic differentiation.Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREBNovel Interaction of Class IIb Histone Deacetylase 6 (HDAC6) with Class IIa HDAC9 Controls Gonadotropin Releasing Hormone (GnRH) Neuronal Cell Survival and MovementRole of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia.Targeting Histone Deacetylases in Diseases: Where Are We?The transposon-driven evolutionary origin and basis of histone deacetylase functions and limitations in disease prevention.Histone Deacetylase 3 Is Required for Efficient T Cell Development.Differential effects of histone deacetylase inhibitors in tumor and normal cells-what is the toxicological relevance?Expression of class II HDACs in two mouse models of temporal lobe epilepsy.Assays for pharmacodynamic analysis of histone deacetylase inhibitors.Class IIa histone deacetylases: regulating the regulators.Anti-Inflammatory Effect of Spirulina platensis in Macrophages Is Beneficial for Adipocyte Differentiation and Maturation by Inhibiting Nuclear Factor-κB Pathway in 3T3-L1 Adipocytes.Polydactyly in mice lacking HDAC9/HDRPHistone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.A class of their own: exploring the nondeacetylase roles of class IIa HDACs in cardiovascular diseaseHistone deacetylases: salesmen and customers in the post-translational modification market.Increased ADAM17 mRNA expression and activity is associated with atherosclerosis resistance in LDL-receptor deficient miceDeregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice.Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis.HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements
P2860
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
P248
Q21144915-6E63D2AD-7F84-4169-AF46-B0B56F2850C7Q24300259-6FFA830B-A937-4C82-9C00-CBD32CE8A899Q24303533-A17C7D57-2495-4758-825B-654098D0615FQ24519076-F3A407EC-488F-4AB5-AF9D-79BF9F5CAB16Q24556900-5EE63AFB-C400-405C-B676-3CCB4055F7FAQ24613278-11ACB00B-0A70-4540-8028-0C092CCB2720Q28077331-21CAAA59-A2A3-453F-8932-ACCCC10F13CBQ28506490-8F7E56F7-6C1C-4181-8E82-6DE5D973BE5CQ28571349-CC227C8C-E873-45F7-83A9-71043320D35AQ28587166-2D1A8EEC-C533-4339-88D4-1AA4D0F33ED7Q29619117-B4967CD5-45A7-4F11-80F2-23275F869B20Q33514116-F280BD02-3E01-44ED-9E7E-47D85684B03CQ33724483-8313D8FB-47B5-4506-8EF8-F99908F349FEQ33772585-4AF78947-EB2A-4636-AD70-B69DDCE84117Q33939057-8051CF46-FCD5-4D53-B244-CA9F946791FCQ34385667-A4026E5C-9D25-49BE-983A-6751FCE446C2Q34440353-5170641C-7247-476C-91AB-A6ACF09370C6Q34531716-09EE9ABA-6553-4BA8-B963-E3ED3D612E4DQ34564841-E506A030-65D6-4765-BA0E-FC219815691FQ34624058-F1F21A66-F3CA-48A7-851B-3503DC11068AQ35145068-1E781051-9872-4776-A74F-1D61201E4820Q35218631-DF93922A-E562-47CD-8F46-CE8B97F0FD70Q35662350-16130D30-B4BF-47D0-A2BC-98C6B64A9682Q35779725-17E32DAB-126B-4B4F-85B5-78D0B3B9F5F7Q35821728-5E3B54DC-862A-4373-A5EC-1AFEB274C464Q36001865-DB7F63B2-43B5-40A2-9686-147ABB55A30AQ36174093-B729115C-DFB9-477E-8BA4-E5033ACD0BBAQ36179533-B81398F9-BAD5-47B8-9366-93B40A58ABF0Q36536614-54B688D5-A4D0-4712-AFA3-14F155AC5ADAQ36546255-2ECCDF48-898B-402E-9B8C-E384267E5F9EQ36908414-7165F910-ADC9-45A6-B176-5F088D9FF8F8Q36996047-E5BED6CC-8FCB-4A6E-B7C7-427FB65D47A8Q37129633-D15BA7E8-6D91-4804-B5B1-A84CCCFCA92DQ37190152-807E272F-CCF6-4FA1-94BE-0458B52587D3Q37218059-62AAFD31-6280-4EAC-9A95-31A2FCD558B2Q37389553-C9B00900-0936-4A7E-A81B-1494AC943BFBQ37461235-20F493D8-C52E-47BC-8630-AE6AD47867EFQ37545385-6E05AD3D-451E-4835-B29A-63BF22AA1855Q37568629-84E7263D-4AC9-441A-A504-C1F017CF8CDCQ38373328-35428574-6ED4-454E-B739-E7F610DF6BF4
P2860
The histone deacetylase 9 gene encodes multiple protein isoforms
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The histone deacetylase 9 gene encodes multiple protein isoforms
@ast
The histone deacetylase 9 gene encodes multiple protein isoforms
@en
The histone deacetylase 9 gene encodes multiple protein isoforms
@en-gb
The histone deacetylase 9 gene encodes multiple protein isoforms
@nl
type
label
The histone deacetylase 9 gene encodes multiple protein isoforms
@ast
The histone deacetylase 9 gene encodes multiple protein isoforms
@en
The histone deacetylase 9 gene encodes multiple protein isoforms
@en-gb
The histone deacetylase 9 gene encodes multiple protein isoforms
@nl
prefLabel
The histone deacetylase 9 gene encodes multiple protein isoforms
@ast
The histone deacetylase 9 gene encodes multiple protein isoforms
@en
The histone deacetylase 9 gene encodes multiple protein isoforms
@en-gb
The histone deacetylase 9 gene encodes multiple protein isoforms
@nl
P2860
P50
P921
P356
P1476
The histone deacetylase 9 gene encodes multiple protein isoforms
@en
P2093
Arthur Zelent
Louise Howell
P2860
P304
P356
10.1074/JBC.M212935200
P407
P577
2003-05-02T00:00:00Z